Ruplizumab

Modify Date: 2024-02-24 10:07:05

Ruplizumab structure	Common Name	Ruplizumab
	CAS Number	220651-94-5	Molecular Weight	N/A
	Density	N/A	Boiling Point	N/A
	Molecular Formula	N/A	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Ruplizumab

Ruplizumab (BG 9588) is a humanized monoclonal anti-CD40L (TNF Receptor) IgG1κ antibody. Ruplizumab has the potential for systemic lupus erythematosus disease research[1].

Name	Ruplizumab
Synonym	More Synonyms

Description	Ruplizumab (BG 9588) is a humanized monoclonal anti-CD40L (TNF Receptor) IgG1κ antibody. Ruplizumab has the potential for systemic lupus erythematosus disease research[1].
Related Catalog	Research Areas >> Inflammation/Immunology
References	[1]. Chris Chamberlain, et al. Repeated administration of dapirolizumab pegol in a randomised phase I study is well tolerated and accompanied by improvements in several composite measures of systemic lupus erythematosus disease activity and changes in whole blood transcriptomic profiles. Ann Rheum Dis. 2017 Nov;76(11):1837-1844.

No Any Chemical & Physical Properties

RUPLIZUMAB

Ruplizumab

Use of Ruplizumab

Names

Ruplizumab Biological Activity

Chemical & Physical Properties

Synonyms